Wednesday, July 8, 2026

pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
Status
Public
HQ
1196 Hwy 3 South, Northfield, MN 55057, US
Founded
2007
Employees
81
Programs
14
Drugs
10
Patents
7
Intelligence · Clinical Trials

Aurinia Pharmaceuticals clinical trials

Registry index of 19 ClinicalTrials.gov studies linked to Aurinia Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Aurinia Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Aurinia Pharmaceuticals.

  1. AUR-200-2024-02 — Phase 2

    Clinical update
  2. voclosporin — Phase 3

    Clinical update
  3. Voclosporin Ophthalmic Solution — Phase 2

    Clinical update
  4. Voclosporin High Dose — Phase 2

    Clinical update
  5. Simvastatin — Phase 1

    Clinical update
  6. 0.05% Voclosporin Ophthalmic Solution (VOS) — Phase 3

    Clinical update
  7. Voclosporin — Phase 3

    Clinical update
  8. Voclosporin — Phase 3

    Clinical update

Trial registry

19 studies